Dr. Jeffrey Lieberman
Dr. Jeffrey Lieberman
The Future of Psychedelics: A Discussion with Rick Doblin & Steven Levine
The Future of Psychedelics: A Discussion with Rick Doblin & Steven Levine
The Future of Psychedelics: A Discussion with Rick Doblin & Steven Levine
Wednesday 29th September 2021
Join Dr. Jeffrey Lieberman with experts Rick Doblin and Steven Levine as they discuss psychedelics' potential in mental health and addiction treatment.
64 minutes
Informative
Thought-provoking
Engaging
Raw
Eye-opening
About this podcast
Author:
Dr. Jeffrey Lieberman
Overview:
Categories:
Body & Mind
Mindfulness & Technology in Health
Innovative Treatments & Recovery Paths
Sobriety Toolkit
Navigating Intimate Relationships
Links:
Visit site
Episodes:
25 (View all)
Do you want to link to this podcast?
Get the buttons here!Psychedelics in Therapy: Insights from Rick Doblin & Steven Levine
Psychedelics are not for people that don't want to take them.
Imagine a world where psychedelics are a cornerstone of mental health treatment. In this thought-provoking episode of 'Shrink Speak', Dr. Jeffrey Lieberman sits down with two trailblazers in the field, Dr. Rick Doblin and Dr. Steven Levine, to discuss just that. Dr. Doblin, the founder of MAPS, and Dr.
Levine, a pioneer in ketamine therapy, bring their extensive experience to the table, exploring how substances like psilocybin, ketamine, LSD, MDMA, and ibogaine could revolutionize the treatment of mental health and addiction disorders. They don't shy away from the tough questions either—delving into the challenges of psychedelic research, the spiritual aspects of these substances, and the evolving landscape of drug policy.
Whether you're curious about the science behind these treatments or interested in their broader societal implications, this episode offers a fascinating glimpse into the future of mental health care.